Justin Renz
Director of Finance/CFO at ARDELYX, INC.
Net worth: 2 M $ as of 2024-04-29
Network origin in Justin Renz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA
28
| Extinct | Pharmaceuticals: Other | 28 |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Subsidiary | Pharmaceuticals: Major | 9 | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Justin Renz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Chief Executive Officer General Counsel Sales & Marketing | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Director/Board Member Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
| Yale University | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| Boston University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal General Counsel | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
| Boston University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Doctorate Degree Masters Business Admin | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| EQRX, INC. | Pharmaceuticals: Major | Founder Founder | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Chief Operating Officer President | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Founder | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| STALLERGENES GREER | Pharmaceuticals: Major | General Counsel Public Communications Contact | |
| Stanford Law School | College/University | Graduate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Graduate Degree | |
| Queen's University | College/University | Graduate Degree Masters Business Admin | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Comptroller/Controller/Auditor General Counsel | |
| BG MEDICINE, INC. | Medical Specialties | Comptroller/Controller/Auditor Director of Finance/CFO |
Statistics
International
| United States | 40 |
| Canada | 7 |
| United Kingdom | 4 |
| Ireland | 2 |
| Sweden | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 16 |
| Commercial Services | 7 |
Operational
| Director/Board Member | 372 |
| Corporate Officer/Principal | 190 |
| Independent Dir/Board Member | 112 |
| Chairman | 63 |
| Undergraduate Degree | 62 |
Most connected contacts
| Insiders | |
|---|---|
| Anthony Evnin | 46 |
| David Mott | 45 |
| Mark Corrigan | 29 |
| Hartley Richardson | 26 |
| Robert M. Forrester | 25 |
| Alexis Borisy | 25 |
| James Edward Thomas | 25 |
| Michael Kauffman | 24 |
| Patrick J. Fortune | 24 |
| Sally Crawford | 22 |
| Bill Hunter | 22 |
| Jan Lundberg | 21 |
| Gordon Ringold | 20 |
| Mike Raab Raab | 20 |
| Mikael Dolsten | 19 |
- Stock Market
- Insiders
- Justin Renz
- Company connections
